iShares MBS ETF (NASDAQ:MBB – Get Free Report) saw a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 6,240,000 shares, a growth of 193.0% from the May 15th total of 2,130,000 shares. Based on an average daily volume of 3,561,800 shares, the short-interest ratio is presently 1.8 days. Currently, 1.6% of the company’s shares are short sold.
iShares MBS ETF Stock Up 0.4%
Shares of iShares MBS ETF stock opened at $93.00 on Friday. The stock’s fifty day moving average is $92.42 and its 200-day moving average is $92.52. iShares MBS ETF has a 12-month low of $90.28 and a 12-month high of $96.76.
iShares MBS ETF Cuts Dividend
The firm also recently declared a monthly dividend, which was paid on Thursday, June 5th. Stockholders of record on Monday, June 2nd were issued a dividend of $0.3251 per share. The ex-dividend date of this dividend was Monday, June 2nd. This represents a $3.90 dividend on an annualized basis and a dividend yield of 4.20%.
Institutional Inflows and Outflows
iShares MBS ETF Company Profile
iShares MBS ETF (the Fund), formerly iShares Barclays MBS Bond Fund, is an exchange-traded fund (ETF). The Fund seeks investment results, which correspond to the price and yield performance of the Barclays Capital U.S. MBS Index (the Index). The Index measures the performance of investment grade mortgage-backed pass-through securities issued by the Government National Mortgage (GNMA).
Read More
- Five stocks we like better than iShares MBS ETF
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- Short Selling – The Pros and Cons
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Dividend Capture Strategy: What You Need to Know
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for iShares MBS ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares MBS ETF and related companies with MarketBeat.com's FREE daily email newsletter.